S
Scott C. Weaver
Researcher at University of Texas Medical Branch
Publications - 584
Citations - 40298
Scott C. Weaver is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Virus & Alphavirus. The author has an hindex of 92, co-authored 536 publications receiving 32230 citations. Previous affiliations of Scott C. Weaver include Mount Sinai St. Luke's and Mount Sinai Roosevelt & Lenox Hill Hospital.
Papers
More filters
Journal ArticleDOI
Genetic and Anatomic Determinants of Enzootic Venezuelan Equine Encephalitis Virus Infection of Culex (Melanoconion) taeniopus
TL;DR: The hypothesis that the enzootic VEEV relationship with C. taeniopus differs from the epizootic virus-vector interaction in that the determinants appear to be found in both the nonstructural and structural regions, and initial midgut infection is not limited to a small population of susceptible cells is supported.
Posted ContentDOI
Role of monkeys in the sylvatic cycle of chikungunya virus in Senegal
Benjamin M. Althouse,Matilde Guerbois,Derek A. T. Cummings,Ousmane M. Diop,Ousmane Faye,Abdourahmane Faye,Diawo Diallo,Bakary Djilocalisse Sadio,Abdourahmane Sow,Oumar Faye,Amadou A. Sall,Mawlouth Diallo,Brenda R. Benefit,Evan Simmons,Douglas M. Watts,Scott C. Weaver,Kathryn A. Hanley +16 more
TL;DR: It is concluded that monkeys in this region serve primarily as amplification rather than reservoir hosts of CHIKV, and additional efforts are needed to identify other vertebrate hosts capable of supporting continuous circulation.
Book ChapterDOI
Structural biology of old world and new world alphaviruses
TL;DR: This work presents a novel and scalable approach that allows for real-time, 3D analysis of the response of the immune system to laser-spot assisted macromolecular imaging.
Journal ArticleDOI
IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers.
Rianna Vandergaast,Timothy S. Carey,Samantha Reiter,Chase Lathrum,Patrycja J. Lech,Clement W. Gnanadurai,Michelle Haselton,Jason Buehler,Riya Narjari,Luke Schnebeck,Anne Roesler,Kara Sevola,Lukkana Suksanpaisan,Alice Bexon,Shruthi Naik,Shruthi Naik,Bethany Brunton,Scott C. Weaver,Grace H. Rafael,Sheryl Tran,Alina Baum,Christos A. Kyratsous,Kah Whye Peng,Kah Whye Peng,Stephen J. Russell,Stephen J. Russell +25 more
TL;DR: The IMMUNO-COV v2.0 as discussed by the authors is a scalable surrogate virus assay, which titrates antibodies that block infection of Vero-ACE2 cells by a luciferase-encoding vesicular stomatitis virus displaying SARS-CoV-2 spike glycoproteins.
Journal ArticleDOI
Transmission potential of two chimeric western equine encephalitis vaccine candidates in Culex tarsalis.
TL;DR: It is suggested that both vaccine candidates are less competent than the parental strains to be transmitted by the primary mosquito vector, Cx.